The role of leukotrienes in the pathogenesis of systemic sclerosis

Systemic sclerosis (SSc, scleroderma) is an autoimmune disease characterized by widespread vascular injury and progressive fibrosis of the skin and internal organs. SSc-related involvement of the lungs, heart, kidneys and/or the gastrointestinal system accounts for the increased mortality of sclerod...

Full description

Bibliographic Details
Main Authors: Sylwia Chwieśko-Minarowska, Krzysztof Kowal, Marek Bielecki, Otylia Kowal-Bielecka
Format: Article
Language:English
Published: Via Medica 2012-07-01
Series:Folia Histochemica et Cytobiologica
Subjects:
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/19348
_version_ 1819229954928279552
author Sylwia Chwieśko-Minarowska
Krzysztof Kowal
Marek Bielecki
Otylia Kowal-Bielecka
author_facet Sylwia Chwieśko-Minarowska
Krzysztof Kowal
Marek Bielecki
Otylia Kowal-Bielecka
author_sort Sylwia Chwieśko-Minarowska
collection DOAJ
description Systemic sclerosis (SSc, scleroderma) is an autoimmune disease characterized by widespread vascular injury and progressive fibrosis of the skin and internal organs. SSc-related involvement of the lungs, heart, kidneys and/or the gastrointestinal system accounts for the increased mortality of scleroderma patients. Despite the progress which has recently been made in this field, the treatment of SSc is still unsatisfactory due to the low efficacy and/or high toxicity of available therapies. Leukotrienes are a family of lipid mediators synthesized from arachidonic acid in a process mediated by 5-lipoxygenase; they include leukotriene B4 and a group of cysteinyl leukotrienes: C4, D4, and E4. Leukotrienes play an important role in the regulation of all the processes vital to the pathogenesis of SSc, namely inflammation, vascular function and connective tissue remodeling. The available data suggests that an excessive synthesis of leukotrienes may contribute to the development and progression of SSc. Accordingly, blockade of leukotriene pathways appears to be a new, promising target for the  reatment of SSc.
first_indexed 2024-12-23T11:21:23Z
format Article
id doaj.art-25d4246b9c1d485c943f7137ab645891
institution Directory Open Access Journal
issn 0239-8508
1897-5631
language English
last_indexed 2024-12-23T11:21:23Z
publishDate 2012-07-01
publisher Via Medica
record_format Article
series Folia Histochemica et Cytobiologica
spelling doaj.art-25d4246b9c1d485c943f7137ab6458912022-12-21T17:49:03ZengVia MedicaFolia Histochemica et Cytobiologica0239-85081897-56312012-07-0150210.5603/FHC.2012.0027The role of leukotrienes in the pathogenesis of systemic sclerosisSylwia Chwieśko-MinarowskaKrzysztof KowalMarek BieleckiOtylia Kowal-BieleckaSystemic sclerosis (SSc, scleroderma) is an autoimmune disease characterized by widespread vascular injury and progressive fibrosis of the skin and internal organs. SSc-related involvement of the lungs, heart, kidneys and/or the gastrointestinal system accounts for the increased mortality of scleroderma patients. Despite the progress which has recently been made in this field, the treatment of SSc is still unsatisfactory due to the low efficacy and/or high toxicity of available therapies. Leukotrienes are a family of lipid mediators synthesized from arachidonic acid in a process mediated by 5-lipoxygenase; they include leukotriene B4 and a group of cysteinyl leukotrienes: C4, D4, and E4. Leukotrienes play an important role in the regulation of all the processes vital to the pathogenesis of SSc, namely inflammation, vascular function and connective tissue remodeling. The available data suggests that an excessive synthesis of leukotrienes may contribute to the development and progression of SSc. Accordingly, blockade of leukotriene pathways appears to be a new, promising target for the  reatment of SSc.http://czasopisma.viamedica.pl/fhc/article/view/19348leukotrienessclerodermaSSc-related insterstitial lung disease
spellingShingle Sylwia Chwieśko-Minarowska
Krzysztof Kowal
Marek Bielecki
Otylia Kowal-Bielecka
The role of leukotrienes in the pathogenesis of systemic sclerosis
Folia Histochemica et Cytobiologica
leukotrienes
scleroderma
SSc-related insterstitial lung disease
title The role of leukotrienes in the pathogenesis of systemic sclerosis
title_full The role of leukotrienes in the pathogenesis of systemic sclerosis
title_fullStr The role of leukotrienes in the pathogenesis of systemic sclerosis
title_full_unstemmed The role of leukotrienes in the pathogenesis of systemic sclerosis
title_short The role of leukotrienes in the pathogenesis of systemic sclerosis
title_sort role of leukotrienes in the pathogenesis of systemic sclerosis
topic leukotrienes
scleroderma
SSc-related insterstitial lung disease
url http://czasopisma.viamedica.pl/fhc/article/view/19348
work_keys_str_mv AT sylwiachwieskominarowska theroleofleukotrienesinthepathogenesisofsystemicsclerosis
AT krzysztofkowal theroleofleukotrienesinthepathogenesisofsystemicsclerosis
AT marekbielecki theroleofleukotrienesinthepathogenesisofsystemicsclerosis
AT otyliakowalbielecka theroleofleukotrienesinthepathogenesisofsystemicsclerosis
AT sylwiachwieskominarowska roleofleukotrienesinthepathogenesisofsystemicsclerosis
AT krzysztofkowal roleofleukotrienesinthepathogenesisofsystemicsclerosis
AT marekbielecki roleofleukotrienesinthepathogenesisofsystemicsclerosis
AT otyliakowalbielecka roleofleukotrienesinthepathogenesisofsystemicsclerosis